SynthesisBMC public health2025
Public awareness and acceptance of malaria vaccine in Sub-Saharan Africa: a systematic review.
Synthesis in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe African continent continues to experience a high prevalence of malaria more than three years after the licensure of the first malaria vaccine. This study aimed to review relevant literature on malaria vaccine awareness and acceptance among the public in sub-Saharan Africa (SSA).
methodsThe Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) Statement of 2020 was used for reporting this systematic review. Related publications were searched from nine public databases. The search was restricted to studies published between January 2021 and March 2025, using the Population, Exposure, Outcome (PEO) framework to assess the eligibility. The Joanna Briggs Institute (JBI) Critical Appraisal Tools were used for critical appraisal, and relevant data were extracted into Microsoft Excel 2016, where they were synthesized.
resultsA total of 33 studies were included in this review, predominantly from West Africa and of cross-sectional design. Malaria vaccine awareness ranged from 7.26% in the Democratic Republic of Congo to 95.6% in Ghana, with healthcare workers as the main information source. Acceptance levels also varied widely, from 10.3% to 100%, and were generally higher in Nigeria and Ghana. Beyond acceptance, participants from both countries were also willing to recommend the vaccine to others. There was scant evidence on the acceptance of malaria vaccines among the vaccine types. Education and occupation were consistently associated with greater awareness and acceptance, while factors such as age, gender, and income showed inconsistent or limited influence. In three African nations (Uganda, Ghana, and Nigeria), higher education was associated with a greater likelihood of vaccine awareness. Employed people also had higher awareness and acceptance of the vaccines in SSA. Moreover, the awareness of the vaccine was associated with its acceptance.
conclusionMalaria vaccine awareness and acceptance in SSA vary widely across regions, with education, occupation, and healthcare workers playing key roles in shaping positive uptake. Hence, more concrete steps are needed to increase regional awareness and acceptance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.